Interpreting the findings of the IMPROVE study

American Journal of Health-System Pharmacy

Volumn 58, Issue 14, 2001, Pages 1330-1337

  Carter, B L ^a   Malone, D C ^a   Billups, S J ^a   Valuck, R J ^a   Barnette, D J ^a   Sintek, C D ^a   Ellis, S ^a   Covey, D ^a   Mason, B ^a   Jue, S ^a   Carmichael, J ^a   Guthrie, K ^a   Dombrowski, R ^a   Geraets, D R ^a   Amato, M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Administration; Clinical pharmacists; Clinical pharmacy; Clinical studies; Costs; Databases; Department of Veterans Affairs; Economics; Interventions; Managed care systems; Methodology; Outcomes; Patient care; Pharmaceutical care; Pharmaceutical services; Pharmacy, institutional, hospital; Primary care; Quality of life; Toxicity

Indexed keywords

ARTICLE; CLINICAL PHARMACY; CLINICAL STUDY; CONTROLLED STUDY; DATA BASE; HEALTH CARE COST; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MANAGED CARE; METHODOLOGY; OUTCOMES RESEARCH; PATIENT CARE; PATIENT SATISFACTION; PATIENT SELECTION; PHARMACEUTICAL CARE; PHARMACY; PRIMARY HEALTH CARE; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 0035879366     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/58.14.1330     Document Type: Article

References (20)

1. Ambulatory care pharmacy services: Has the agenda changed?
2. The IMPROVE study: Background and study design
3. Characteristics of ambulatory care clinics and pharmacists in Veterans Affairs medical centers
4. Behavioral pharmaceutical care scale for measuring pharmacists' activities
5. Assessing the structure and process for providing pharmaceutical care in Veterans Affairs medical centers
6. Recommended guidelines for pharmacists who provide care for patients in the IMPROVE study
7. Indicators for the selection of ambulatory patients who warrant pharmacist monitoring
8. Development of a chronic disease indicator score using a Veterans Affairs medical center medication database
9. A chronic disease score from automated pharmacy data
10. Estimating risk factors for patients with potential drug-related problems using electronic pharmacy data
11. The MOS 36-item short form health survey (SF-36), I: Conceptual framework and item selection
12. The MOS 36-item short form health survey (SF-36), II: Psychometric and clinical tests of validity in measuring physical and mental health constructs
13. The MOS short form general health survey: Reliability and validity in a patient population
14. The relationship between medication non-compliance and patient characteristics, health-related quality of life, and health care costs
15. Why people use health services
16. Types of interventions made by clinical pharmacists in the IMPROVE study
17. An economic analysis of a randomized controlled multi-center study of clinical pharmacist interventions for high-risk veterans: The IMPROVE study
18. Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems?
19. Antihypertensive drug utilization in hypertensive veterans with complex medication profiles
20. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: The IMPROVE study